Remove Chemotherapy Remove Drug Development Remove Magazine
article thumbnail

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. Chemotherapy still accounted for 72.6% Mei says that oncology is one of the key region-specific unmet medical needs Antengene is hoping to address with innovative drugs.

article thumbnail

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharmaceutical Technology

Go deeper with GlobalData Reports Chemotherapy in Pharmaceuticals: Platinum-based cancer drug composi. Further, they say the balance attempted between encouraging innovation and improving access instead could be contradictory for drug developers and investors, in a way that is emblematic of a fragmented EU.